Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKropz Plc Regulatory News (KRPZ)

Share Price Information for Kropz Plc (KRPZ)

Share Price is delayed by 15 minutes
Get Live Data
1.25    0.00 (0.00%)
Bid:
1.20
Ask:
1.30
Spread: 0.10 (8.333%)
Market Cap: £20.59m
KRPZ Live PriceLast checked at - London Stock Exchange

Intraday Kropz Plc Share Chart

Equity Facility Draw Down

7 Mar 2022 07:00

RNS Number : 7475D
Kropz PLC
07 March 2022
 

7 March 2022

Kropz Plc

("Kropz" or the "Company")

 

Equity Facility Draw Down

 

Kropz Plc (AIM: KRPZ), an emerging African phosphate explorer and developer, is pleased to confirm that it has made a further quarterly draw down request under one of the equity facilities with its major shareholder, the ARC Fund ("ARC"). The Company had/has three equity facilities with ARC:

- the first being for an amount of US$ 40 million (which cannot exceed ZAR 680 million), as announced on 13 May 2020 ("Original Equity Facility");

- the second for an amount of up to US$ 5 million (which cannot exceed ZAR 85 million), as announced on 26 February 2021 ("New Equity Facility"); and

- the third for a total commitment of up to ZAR 200 million to be provided by ARC, as announced on 29 September 2021 ("New ZAR Equity Facility").

 

As announced on 7 September 2021, the Original Equity Facility is fully drawn down. In accordance with the terms of the Original Equity Facility, any fees associated with the bank guarantee provided by ARC, would be settled by the issue of new ordinary shares to ARC. ARC notified the Company that the final guarantee fees due to ARC amounted to US$311,733. These fees will be settled by the issue of 3,971,712 new ordinary shares at the issue price of 6.75 pence per share to ARC on 10 March 2022.

 

In addition, the Company has made the fifth and final draw down request of US$ 200,000 under the New Equity Facility. This draw down will be settled by the issue of 3,474,536 new ordinary shares at the issue price of 4.20 pence per share to ARC on 10 March 2022. The proceeds drawn down from the New Equity Facility will be utilised for general corporate purposes.

 

To date ZAR 127 million has been drawn down on the New ZAR Equity Facility. The remaining ZAR 73 million can be drawn down by the Company, at the sole discretion of ARC.

 

Admission and Total Voting Rights

 

Application will be made for the 7,446,248 new ordinary shares to admission to trading on the AIM Market of the London Stock Exchange ("AIM"). It is expected that admission will become effective and that dealings in the new ordinary shares will commence at 8.00 a.m. on 10 March 2022 ("Admission").

 

On Admission, the Company's issued share capital will consist of 923,718,223 ordinary shares with voting rights. There are no shares held in treasury. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Change in Shareholding

 

Following issue of the 7,446,248 new ordinary shares, ARC will be directly interested in 768,339,330 ordinary shares of the Company representing 83.2 per cent. of the issued share capital.

 

In addition, ARC holds call options over certain shares held by Kropz International S.a.r.l as set out in the announcement on 26 February 2021.

 

 

For further information visit www.kropz.com or contact:

 

Kropz Plc

 

Mark Summers (CEO)

+27 (0) 79 744 8708

 

 

Grant Thornton UK LLP

Nominated Adviser

Samantha Harrison

Harrison Clarke

George Grainger

Ciara Donnelly

+44 (0) 20 7383 5100

 

 

Hannam & Partners

Broker

Andrew Chubb

Ernest Bell

 +44 (0) 20 7907 8500

 

 

Tavistock

Financial PR & IR (UK)

Nick Elwes

Jos Simson

Oliver Lamb

+44 (0) 207 920 3150

kropz@tavistock.co.uk

 

 

R&A Strategic Communications

PR (South Africa)

James Duncan

+27 (0) 11 880 3924

james@rasc.co.za 

 

About Kropz Plc

Kropz is an emerging African explorer and developer of plant nutrient feed minerals with phosphate projects in South Africa and the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.

-ENDS-

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLRVSISIIF
Date   Source Headline
23rd Jul 202112:29 pmRNSResult of General Meeting
19th Jul 20213:47 pmRNSUpdate regarding General Meeting Arrangements
9th Jul 20214:41 pmRNSSecond Price Monitoring Extn
9th Jul 20214:35 pmRNSPrice Monitoring Extension
2nd Jul 20213:16 pmRNSIssue of LTIP Awards
30th Jun 20211:58 pmRNSResult of AGM
30th Jun 20217:00 amRNSFinal Results, Posting of Annual Report & Accounts
30th Jun 20217:00 amRNSTotal Voting Rights
16th Jun 20214:42 pmRNSSecond Price Monitoring Extn
16th Jun 20214:36 pmRNSPrice Monitoring Extension
16th Jun 20213:16 pmRNSEquity Facility Draw Downs
16th Jun 202111:05 amRNSSecond Price Monitoring Extn
16th Jun 202111:00 amRNSPrice Monitoring Extension
7th Jun 20217:00 amRNSNotice of AGM and Corporate Update
25th May 20217:00 amRNSElandsfontein and Hinda Update
31st Mar 20217:00 amRNSTotal Voting Rights
3rd Mar 20214:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20214:35 pmRNSPrice Monitoring Extension
3rd Mar 20217:00 amRNSEquity Facility Draw Downs
26th Feb 20217:00 amRNSNew Convertible Facility Agreement
16th Feb 202110:50 amRNSDisposal of Aflao Project
4th Feb 20217:00 amRNSHinda Update
2nd Feb 20217:00 amRNSElandsfontein Update
20th Jan 20217:00 amRNSElandsfontein Update regarding Water Tribunal
9th Dec 20207:00 amRNSEquity Facility Draw Down
30th Sep 20207:00 amRNSManagement Update
24th Sep 20207:00 amRNSEquity Facility Draw Down
9th Sep 20202:36 pmRNSEquity Facility Quarterly Draw Down Update
3rd Sep 20207:00 amRNSElandsfontein Update regarding Water Tribunal
28th Aug 202012:00 pmRNSResult of AGM
26th Aug 20207:00 amRNSUnaudited Half Year Results for H1 2020
20th Aug 20207:00 amRNSElandsfontein Update regarding Water Tribunal
6th Aug 20207:00 amRNSHinda Logistics Study
4th Aug 20207:00 amRNSCEO Appointment & Issue of LTIP Awards & Warrants
3rd Aug 20207:00 amRNSFinal Results, Annual Report and Notice of GM
29th Jun 20207:00 amRNSResults of Open Offer
25th Jun 20204:29 pmRNSEquity Facility & BNP Update & Share Issue
19th Jun 20207:00 amRNSOpen Offer & Equity Facility Update
12th Jun 20207:00 amRNSExtension of Open Offer Closing Date
10th Jun 20203:29 pmRNSEquity Facility Draw Down Update
1st Jun 20207:00 amRNSPlacing and Open Offer
29th May 202011:48 amRNSResults of GM and Equity Facility Draw Down
29th May 20207:00 amRNSUpdate Regarding BNP Facility
21st May 202012:35 pmRNSChange of Registered Office
13th May 20201:29 pmRNSEquity Facility, Proposed Fundraising & GM Notice
25th Mar 20207:00 amRNSCovid-19 Update and South African Directive
16th Mar 202011:46 amRNSElandsfontein Update
26th Feb 20207:01 amRNSCEO Resignation
26th Feb 20207:00 amRNSLoan Facility
14th Feb 20201:20 pmRNSCorporate and Operational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.